CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 129 filers reported holding CHEMOCENTRYX INC in Q4 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $644,000 | +139.4% | 12,474 | +14.9% | 0.01% | +66.7% |
| Q2 2022 | $269,000 | +29.3% | 10,858 | +31.2% | 0.01% | +200.0% |
| Q1 2022 | $208,000 | -60.1% | 8,276 | -42.2% | 0.00% | -77.8% |
| Q4 2021 | $521,000 | +146.9% | 14,318 | +15.5% | 0.01% | +80.0% |
| Q3 2021 | $211,000 | +210.3% | 12,392 | +144.2% | 0.01% | +150.0% |
| Q2 2021 | $68,000 | -62.8% | 5,075 | +42.3% | 0.00% | -33.3% |
| Q1 2021 | $183,000 | +120.5% | 3,566 | +165.9% | 0.00% | 0.0% |
| Q4 2020 | $83,000 | -20.2% | 1,341 | -29.6% | 0.00% | +200.0% |
| Q3 2020 | $104,000 | -76.6% | 1,906 | -75.3% | 0.00% | -94.4% |
| Q2 2020 | $444,000 | +125.4% | 7,721 | +54.6% | 0.02% | +12.5% |
| Q4 2019 | $197,000 | +2088.9% | 4,993 | +245.5% | 0.02% | +1500.0% |
| Q3 2019 | $9,000 | -69.0% | 1,445 | -53.5% | 0.00% | -50.0% |
| Q2 2019 | $29,000 | +866.7% | 3,106 | +1108.6% | 0.00% | – |
| Q4 2018 | $3,000 | -62.5% | 257 | -58.9% | 0.00% | -100.0% |
| Q3 2018 | $8,000 | -91.0% | 626 | -90.8% | 0.00% | -80.0% |
| Q2 2018 | $89,000 | +229.6% | 6,793 | +246.2% | 0.01% | +150.0% |
| Q1 2018 | $27,000 | -25.0% | 1,962 | -67.9% | 0.00% | -60.0% |
| Q4 2017 | $36,000 | +9.1% | 6,107 | +36.9% | 0.01% | +66.7% |
| Q3 2017 | $33,000 | +32.0% | 4,461 | +32.8% | 0.00% | 0.0% |
| Q4 2016 | $25,000 | +733.3% | 3,358 | +345.9% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 753 | +276.5% | 0.00% | – |
| Q4 2015 | $2,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q2 2015 | $1,000 | -85.7% | 100 | -88.6% | 0.00% | -100.0% |
| Q1 2015 | $7,000 | -75.0% | 881 | -86.0% | 0.00% | -66.7% |
| Q3 2014 | $28,000 | +2700.0% | 6,278 | +2441.7% | 0.00% | – |
| Q1 2014 | $1,000 | -91.7% | 247 | -88.5% | 0.00% | -100.0% |
| Q4 2013 | $12,000 | +500.0% | 2,152 | +391.3% | 0.00% | – |
| Q3 2013 | $2,000 | – | 438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |